Related to Agilent Acquires Cancer In Vitro Diagnostic Firm Dako for $2.2B in Cash

• QuantRx Creates Joint Venture with NuRx Focused on Point-of-Care Products
  
• MP Biomedicals to Develop Alzheimer’s Blood Test Based on UCLA Technology
  
• ImmunoVaccine Technologies Collaborates with Scancell to Advance DNA Vaccine Delivery
  
• Horizon Gains Patents to Cell Lines that Model Genetic Mutations Seen in Cancer
  
• Vernalis Earns $6M Up Front in Oncology Deal with GSK
  
• Viral Genetics Forms Anticancer Subsidiary to Exploit Metabolic Disruption Technology
  
• Genentech and Dako Collaborate on Submitting Companion Diagnostic for Herceptin Use in Stomach Cancer to FDA
  
• Arup Taps Epigenomics’ mSEPT9 Biomarker to Develop Colorectal Cancer Test
  
• Clinical Reference Sets Up U.K. Lab along with Quotient Bioresearch
  
• Warnex Develops Test to Detect Swine Flu Virus Mutation Linked to Tamiflu Resistance
  
• Facet Biotech Steps Up to Help Trubion Advance Early-Stage Anticancer Agent with a $20M Fee
  
• Thermo Fisher Scientific Picks Up B.R.A.H.M.S. for $470.46M to Pad Diagnostic Portfolio
  
• Scientists Uncover Molecular Pathway that Makes Tumors More Aggressive
  
• Rosetta's miRNA-Based Cancer Tests Break Into European Market through Distribution Deal with AXA
  
• PerkinElmer Makes Two Acquisitions to Pad Diagnostics Business in Emerging Markets
  
• Qiagen Releases Influenza A/H1N1 Detection Kit for Research Purposes
  
• BioMarker Strategies Secures $1.7M to Expedite Live Tumor Cell Testing System
  
• Access Pharma Taps Accupac to Manufacture Oral Mucositis Therapy in North America
  
• AbD Serotec and FIND to Develop Heat-Stable Antibodies for Diagnostics to Be Leveraged in Tropical Climates
  
• Karus Taps Queen Mary, University of London's Expertise for PI3K Inhibitor Development